Randomized trial comparing same-day discharge with overnight hospital stay after percutaneous coronary intervention: Results of the Elective PCI in Outpatient Study (EPOS)

Circulation

Volumn 115, Issue 17, 2007, Pages 2299-2306

  Heyde, Gerlind S ^a   Koch, Karel T ^a,b   De Winter, Robbert J ^a   Dijkgraaf, Marcel G W ^a   Klees, Margriet I ^a   Dijksman, Lea M ^a   Piek, Jan J ^a   Tijssen, Jan G P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Aftercare; Angioplasty; Cost benefit analysis; Day care; Randomized controlled trials

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ELECTIVE SURGERY; FEASIBILITY STUDY; FEMALE; HEART INFARCTION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REOPERATION; SAFETY; SURGICAL APPROACH;

AMBULATORY CARE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; COST-BENEFIT ANALYSIS; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; NIGHT CARE; PATIENT DISCHARGE; PATIENT SATISFACTION; PATIENT SELECTION; TREATMENT OUTCOME;

EID: 34247624151     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.591495     Document Type: Article

References (24)

1. CAPTURE Investigators. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet. 1997;349:1429-1435.
2. EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 1994;330:956-961.
3. EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med. 1997;336:1689-1697.
4. Koch KT, Piek JJ, Prins MH, de Winter RJ, Mulder K, Lie KI, Tijssen JGP. Triage of patients for short term observation after elective coronary angioplasty. Heart. 2000;83:557-563.
5. Koch KT, Piek JJ, de Winter RJ, David GK, Mulder KJ, Lie KI. Short-term (4 hours) observation after elective coronary angioplasty. Am J Cardiol. 1997;80:1591-1594.
6. Koch KT, Piek JJ, de Winter RJ, Mulder K, David GK, Lie KI. Early ambulation after coronary angioplasty and stenting with six French guiding catheters and low-dose heparin. Am J Cardiol. 1997;80:1084-1086.
7. Ormiston JA, Shaw B, Panther MJ, Ruygrok PN, Devlin GP, Stewart RAH, Webster MWI. Percutaneous coronary intervention with bivalirudin anticoagulation, immediate sheath removal, and early ambulation: a feasibility study with implications for day-stay procedures. Catheter Cardiovasc Interv. 2002;55:289-293.
8. Banning AP, Ormerod OJM, Channon K, McKenna CJ, Orr W, Boulton B, Bashir Y, Forfar JC. Same day discharge following elective percutaneous coronary intervention in patients with stable angina. Heart. 2003;89:665.
9. Ziakas AA, Klinke BP, Mildenberger CR, Fretz DE, Williams EMB, Kinloch FRD, Hilton GJD. Safety of same-day-discharge radial percutaneous coronary intervention: a retrospective study. Am Heart J. 2003;145:278-284.
10. Slagboom T, Kiemeneij F, Laarman GJ, van der Wieken R, Odekerken D. Actual outpatient PTCA: results of the OUTCLAS pilot study. Catheter Cardiovasc Interv. 2001;53:204-208.
11. Kiemeneij F, Laarman GJ, Slagboom T, van der Wieken R. Outpatient coronary stent implantation. J Am Coll Cardiol. 1997;29:323-327.
12. Koch KT, Piek JJ, de Winter RJ, David G, Mulder KJ, Tijssen JGP, Lie KI. Safety of low dose heparin in elective coronary angioplasty. Heart. 1997;77:517-522.
13. Barber JA, Thompson SG. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med. 2000;19:3219-3236.
14. Dunnett CW, Gent M. Significance testing to establish equivalence between treatments with special reference to data in the form of 2x2 tables. Biometrics. 1977;33:593-602.
15. Oweida SW, Roubin GS, Smith RB, Salam AA. Postcatheterization vascular complications associated with percutaneous transluminal coronary angioplasty. J Vasc Surg. 1990;12:310-315.
16. Kiemeneij F, Laarman GJ, Slagboom T, Stella P. Transradial Palmaz-Schatz coronary stenting on an outpatient basis: results of a prospective pilot-study. J Invasive Cardiol. 1995;7(suppl A):A5-A11.
17. Bhatt DL, Raymond RE, Feldman T, Braden GA, Murphy B, Strumpf R, Rogers EW, Myla S, Knopf WD. Successful "pre-closure" of 7Fr and 8Fr femoral arteriotomies with a 6Fr suture-based device (the Multicenter Interventional Closer Registry). Am J Cardiol. 2002;89:777-779.
18. Baim DS, Knopf WD, Hinohara T, Schwarten DE, Schatz RA, Pinkerton CA, Cutlip DE, Fitzpatrick M, Ho KKL, Kuntz RE. Suture-mediated closure of the femoral access site after cardiac catheterization: results of the Suture to Ambulate and Discharge (STAND I and STAND II) trials. Am J Cardiol. 2000;85:864-869.
19. Gerckens U, Cattelaens N, Lampe E-G, Grube E. Management of arterial puncture site after catheterization procedures: evaluating a suture-mediated closure device. Am J Cardiol. 1999;83:1658-1663.
20. Koreny M, Riedmuller E, Nikfardjam M, Siostrzonek P, Mullner M. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA. 2004;291:350-357.
21. Nikolsky E, Mehran R, Halkin A, Aymong ED, Mintz GS, Lasic Z, Negoita M, Fahy M, Krieger S, Moussa I. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol. 2004;44:1200-1209.
22. Carere G, Webb JG, Buller CE, Wilson M, Rahman T, Spinelli J, Anis AH. Suture closure of femoral arterial puncture sites after coronary angioplasty followed by same-day discharge. Am Heart J. 2000;139:52-58.
23. Dalby M, Davies J, Rakhit R, Mayet J, Foale R, Wyn Davies D. Feasibility and safety of day-case transfemoral coronary stenting. Catheter Cardiovasc Interv. 2003;60:18-24.
24. Lincoff AM, Kleiman NS, Kereiakis DJ, Feit F, Bittl JA, Jackman JD, Sarembock IJ, Cohen DJ, Spriggs D, Ebrahimi R, Keren G, Carr J, Cohen EJ, Betriu A, Desmet W, Rutsch W, Wilcox RG, de Feyter PJ, Vahanian A, Topol EJ, for the REPLACE-2 Investigators. Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. JAMA. 2004,292:696-703.